Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
T-MAXIMUM PHARMACEUTICAL Announces Latest Clinical Advances in Allogeneic CAR-T Cell Therapy Breakthrough for Solid Tumors 2024-08-08 20:00
MALAYSIA HEALTHCARE TRAVEL COUNCIL (MHTC) CONTINUES TO ENHANCE AND ELEVATE THEIR "EXPERIENCE MALAYSIA HEALTHCARE (EMH) STORIES" SERIES WITH EPISODE 3 2024-08-08 16:10
WuXi Biologics and Medigene Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers 2024-08-08 16:00
WestGene to Advance Clinical Trials Following Dual IND Approvals for World's First EB Virus-Related mRNA Therapeutic Cancer Vaccine 2024-08-08 10:59
Morinaga Nutritional Foods Vietnam Promoting Sustainable Development with Advanced Technology, Unique functional ingredient, and Green Production 2024-08-08 10:56
Fierce Competition and Technological Innovation Drive Diabetes Care Devices Market Towards Explosive Growth 2024-08-08 00:00
PeproMene Bio announced study demonstrating strong polyfunctionality of novel chimeric antigen receptor (CAR) T cells 2024-08-07 23:37
Concord Medical Regains Compliance with NYSE Minimum Price Requirement 2024-08-07 20:30
Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States 2024-08-07 20:00
I-Mab Appoints U.S. Auditor, PricewaterhouseCoopers LLP (PwC) 2024-08-07 19:00
Sanyou Pharmaceuticals and JiAnTeBo Biotechnology Forge Strategic Partnership to Jointly Develop New Agonist Antibody Drugs 2024-08-07 18:00
Docquity Drives Demand for SIT Pharma's Duo Probiotics in Thailand, Achieving 31% Sales Growth in 6 months 2024-08-07 10:05
GSK's Jemperli (dostarlimab) plus chemotherapy approved in Singapore as the first frontline immuno-oncology treatment for dMMR/MSI-H primary advanced or recurrent endometrial cancer 2024-08-07 09:00
Senhwa Biosciences receives US FDA Study May Proceed letter for the Phase I/II study of Silmitasertib (CX-4945) in combination with chemotherapy in children and young adults with relapsed refractory solid tumors 2024-08-07 08:49
Datasea's Digital Technology Subsidiary Selected as Prospective Partner for Future Projects with Subsidiary of China Mobile 2024-08-06 21:30
Antimicrobial Materials Sector Surges Amid Hygiene and Health Revolution 2024-08-06 21:00
Lunit's AI for Tuberculosis Detection Tops in 12-Product Comparative Study 2024-08-06 21:00
PHYLEX VACCINE ON TRACK TO COMBAT DEADLY NIPAH VIRUS WITH POSITIVE RESULTS OF IMMUNOGENICITY STUDY 2024-08-06 20:00
Samsung Biologics joins the Pharmaceutical Supply Chain Initiative as Supplier Partner 2024-08-06 19:00
Latest Updates of Viva Biotech's Portfolio Companies 2024-08-06 18:47
1 51 52 53 54 55 1596